Edition:
India

Eton Pharmaceuticals Inc (ETON.OQ)

ETON.OQ on NASDAQ Stock Exchange Global Market

7.14USD
20 Sep 2019
Change (% chg)

$0.47 (+7.05%)
Prev Close
$6.67
Open
$6.90
Day's High
$7.41
Day's Low
$6.90
Volume
244,510
Avg. Vol
25,473
52-wk High
$10.20
52-wk Low
$5.14

Latest Key Developments (Source: Significant Developments)

Eton Pharmaceuticals Posts Qtrly Loss Per Share Of $0.18
Wednesday, 7 Aug 2019 

Aug 6 (Reuters) - Eton Pharmaceuticals Inc ::ETON ANNOUNCES SECOND QUARTER FINANCIAL RESULTS AND HIGHLIGHTS BUSINESS PROGRESS.ETON PHARMACEUTICALS INC - REPORTED NO REVENUE IN Q2 OF 2019 VERSUS NO REVENUE FOR SAME PERIOD IN 2018.ETON PHARMACEUTICALS INC - AS OF JUNE 30, ETON REPORTED CASH AND CASH EQUIVALENTS OF $14.9 MILLION COMPARED TO $26.7 MILLION AS OF DECEMBER 31, 2018.ETON PHARMACEUTICALS INC QTRLY LOSS PER SHARE $0.18.  Full Article

Eton Pharmaceuticals Announces FDA Acceptance Of New Drug Application For Et-105
Thursday, 1 Aug 2019 

Aug 1 (Reuters) - Eton Pharmaceuticals Inc ::ETON PHARMACEUTICALS ANNOUNCES FDA ACCEPTANCE OF NEW DRUG APPLICATION FOR ET-105.ETON PHARMACEUTICALS INC - FDA HAS ASSIGNED APPLICATION A PRESCRIPTION DRUG USER FEE ACT (PDUFA) TARGET ACTION DATE OF MARCH 17, 2020..ETON PHARMACEUTICALS INC - FDA HAS ASSIGNED APPLICATION A PRESCRIPTION DRUG USER FEE ACT (PDUFA) TARGET ACTION DATE OF MARCH 17, 2020.  Full Article

Eton Pharmaceuticals Qtrly Loss Per Share $2.24
Monday, 25 Mar 2019 

March 25 (Reuters) - Eton Pharmaceuticals Inc ::ETON PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2018 FINANCIAL RESULTS AND HIGHLIGHTS BUSINESS PROGRESS.ETON PHARMACEUTICALS INC QTRLY LOSS PER SHARE $2.24.ETON PHARMACEUTICALS INC - AS OF DECEMBER 31, 2018, REPORTED CASH AND CASH EQUIVALENTS OF $26.7 MILLION COMPARED TO $13.2 MILLION AT DEC 31, 2017.  Full Article

Bausch Health Companies Acquires Eton Pharmaceuticals' EM-100 Investigational Eye Drop
Tuesday, 19 Feb 2019 

Feb 19 (Reuters) - Bausch Health Companies Inc ::BAUSCH HEALTH ACQUIRES ETON PHARMACEUTICALS' EM-100 INVESTIGATIONAL EYE DROP FOR THE TREATMENT OF ITCHY EYES ASSOCIATED WITH ALLERGIES.BAUSCH HEALTH COMPANIES INC - EM-100 HAS BEEN SUBMITTED TO FDA FOR REVIEW.  Full Article

Eton Pharmaceuticals Reports Third Quarter Loss Per Share $0.65
Thursday, 20 Dec 2018 

Dec 20 (Reuters) - Eton Pharmaceuticals Inc ::ETON PHARMACEUTICALS REPORTS THIRD QUARTER RESULTS AND BUSINESS UPDATE.ETON PHARMACEUTICALS INC QUARTERLY LOSS PER SHARE $0.65.  Full Article

Eton Pharmaceuticals Shares Open About 6.5 pct Above IPO Price in Debut
Tuesday, 13 Nov 2018 

Nov 13 (Reuters) - Eton Pharmaceuticals Inc ::ETON PHARMACEUTICALS SHARES OPEN AT $6.39 IN DEBUT ON THE NASDAQ VERSUS IPO PRICE OF $6.00/SHARE.  Full Article